Catheter Precision, INC Schedule 13G passive stakes

SEG JETS SPV I, LLC has reported beneficial ownership of 1,065,620 shares of Catheter Precision, Inc. common stock, representing 9.79% of the class.

Catheter Precision, Inc. has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Volato Group, Inc. following a private placement.

Multiple C/M Capital entities and associated individuals have filed a Schedule 13G, reporting 0% beneficial ownership of Catheter Precision, Inc. common stock as of March 31, 2026.

Jonathan Juchno and affiliated entities disclose a combined 9.6% beneficial ownership stake in Catheter Precision, Inc. common stock.

Gregory Castaldo has disclosed a 7.5% beneficial ownership stake in Catheter Precision, Inc., holding 176,674 shares of common stock.

Joseph Reda has reported a 7.5% beneficial ownership stake in Catheter Precision, Inc., holding 176,674 shares of common stock.

Armistice Capital, LLC reports a decreased ownership stake in Catheter Precision, Inc., falling below the 5% threshold.

Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a 9.99% beneficial ownership stake in Catheter Precision, Inc., holding 1,000,849 shares of common stock.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a shared beneficial ownership of 9.99% in Catheter Precision, Inc.'s common stock as of December 31, 2024.